Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that HETLIOZ® (tasimelteon) improved sleep quality and increased sleep duration in patients with Smith-Magenis Syndrome (SMS) in a pivotal placebo controlled clinical...
Read morePhoenix Life Sciences International Limited (OTC: PLSI) (Phoenix Life), an international adaptive healthcare solutions company, today announced it has completed the last stages the consolidation of businesses and received approval from the...
Read morePhoenix Life Sciences International Limited (OTCMarkets: PLSI) (Phoenix Life), an international adaptive healthcare solutions company, today announced that it has received an import certificate from the Republic of Vanuatus Minister of Health to...
Read morePhoenix Life Sciences International Limited (Phoenix Life) (OTC: PLSI), an international adaptive healthcare solutions company, today announced that it has retired additional convertible debt, positioning the company with no more outstanding...
Read moreMEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the Company or Medifirst), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug...
Read moreOpGen, Inc. (NASDAQ: OPGN) today reported financial and operating results for the three and nine months ended September 30, 2018 and provided a business update. Total revenue for the third quarter of 2018 was $0.6 million, compared with $0.7...
Read moreDurham, NC November 21, 2018 Heat Biologics, Inc. (Heat) (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies with the goal of activating a patients immune system against cancer through T-cell activation, today announced the...
Read moreFuse Medical, Inc., (OTC: FZMD), (Fuse or the Company), a contract manufacturer and national distributor of medical devices, announced that it has been named Number 56 on Deloittes 2018 Technology Fast 500 TM (Technology Fast 500 TM), an annual...
Read moreCAMBRIDGE, Mass., November 20, 2018 Sage Therapeutics, Inc. (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the U.S. Food...
Read moreCareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced the closing of its...
Read moreGeospace Technologies (NASDAQ: GEOS) today announced that it narrowed its net loss to $19.2 million, or $1.45 per diluted share, on revenue of $75.7 million for its fiscal year ended September 30, 2018. This compares with a net loss of $56.8...
Read more